Table 1. Detailed description of risk of bias assessment using Newcastle-Ottawa Scale (NOS).
Domains | Predefined criteria | Maximum number of stars per domain | |
---|---|---|---|
Selection | Representativeness of exposed cohort (children with CP and visual impairment) |
* Cohort truly representative of the average child with a primary CP aged 0–18 or 0–21 years in the community together with a description of key characteristics (age, gender, tumour type etc.) • Selected group of children with CP (e.g. only giant CP) • No description of key characteristics |
**** |
Selection of non-exposed cohort (children with CP without visual impairment) | * Cohort drawn from the same community as the exposed cohort • Cohort drawn from a different source • No description of the derivation of the non-exposed cohort |
||
Ascertainment of exposure (CP) | * Medical records / histological confirmation • No description |
||
Demonstration that outcome of interest (visual impairment) was not necessarily present at start of study | * Outcome of interest was not an inclusion criterion for study • Outcome of interest was an inclusion criterion for study |
||
Comparability | Comparability of cohorts on the basis of the design of analysis | NA or for studies with > 1 cohort: * Only children (aged 0–21 years) included in both cohorts * Tumour locations were reported in both cohorts |
NA or ** |
Outcome | Assessment of outcome | * VA and VF were reported • Only global information about visual function at diagnosis |
* |
Was follow-up long enough for outcomes to occur | NA | ||
Adequacy of follow-up of cohorts | NA |
CP: Craniopharyngioma. NA: Not applicable. Items do not apply to the research question and design of this review.